178 related articles for article (PubMed ID: 17591568)
21. Preoperative intensity-modulated radiotherapy and chemotherapy for locally advanced vulvar carcinoma.
Beriwal S; Coon D; Heron DE; Kelley JL; Edwards RP; Sukumvanich P; Zorn KK; Krivak TC
Gynecol Oncol; 2008 May; 109(2):291-5. PubMed ID: 18455637
[TBL] [Abstract][Full Text] [Related]
22. Molecular PET/CT imaging-guided radiation therapy treatment planning.
Zaidi H; Vees H; Wissmeyer M
Acad Radiol; 2009 Sep; 16(9):1108-33. PubMed ID: 19427800
[TBL] [Abstract][Full Text] [Related]
23. Advances in nasopharyngeal carcinoma.
Guigay J
Curr Opin Oncol; 2008 May; 20(3):264-9. PubMed ID: 18391624
[TBL] [Abstract][Full Text] [Related]
24. [Radiotherapy indications in non-Hodgkin lymphoma].
Quero L; Hennequin C; Brice P
Cancer Radiother; 2009 Oct; 13(6-7):471-8. PubMed ID: 19695926
[TBL] [Abstract][Full Text] [Related]
25. Proton therapy in a pediatric patient with stage III Hodgkin lymphoma.
Holtzman A; Flampouri S; Li Z; Mendenhall NP; Hoppe BS
Acta Oncol; 2013 Apr; 52(3):592-4. PubMed ID: 23477362
[No Abstract] [Full Text] [Related]
26. Neoadjuvant chemoradiation versus chemotherapy for patients undergoing esophagectomy for esophageal cancer.
Luu TD; Gaur P; Force SD; Staley CA; Mansour KA; Miller JI; Miller DL
Ann Thorac Surg; 2008 Apr; 85(4):1217-23; discussion 1223-4. PubMed ID: 18355499
[TBL] [Abstract][Full Text] [Related]
27. Helical tomotherapy as a new treatment technique for whole abdominal irradiation.
Rochet N; Sterzing F; Jensen A; Dinkel J; Herfarth K; Schubert K; Eichbaum M; Schneeweiss A; Sohn C; Debus J; Harms W
Strahlenther Onkol; 2008 Mar; 184(3):145-9. PubMed ID: 18330510
[TBL] [Abstract][Full Text] [Related]
28. The Stanford V regimen is effective in patients with good risk Hodgkin lymphoma but radiotherapy is a necessary component.
Abuzetun JY; Loberiza F; Vose J; Bierman P; Bociek RG; Enke C; Bast M; Weisenburger D; Armitage JO;
Br J Haematol; 2009 Feb; 144(4):531-7. PubMed ID: 19055670
[TBL] [Abstract][Full Text] [Related]
29. Individualized estimates of second cancer risks after contemporary radiation therapy for Hodgkin lymphoma.
Hodgson DC; Koh ES; Tran TH; Heydarian M; Tsang R; Pintilie M; Xu T; Huang L; Sachs RK; Brenner DJ
Cancer; 2007 Dec; 110(11):2576-86. PubMed ID: 17941006
[TBL] [Abstract][Full Text] [Related]
30. New strategies for the treatment of advanced-stage Hodgkin's lymphoma.
Diehl V; Engert A; Re D
Hematol Oncol Clin North Am; 2007 Oct; 21(5):897-914. PubMed ID: 17908627
[TBL] [Abstract][Full Text] [Related]
31. Induction chemotherapy in Barrett cancer: influence on surgical risk and outcome.
Siewert JR; Lordick F; Ott K; Stein HJ; Weber WA; Becker K; Peschel C; Fink U; Schwaiger M
Ann Surg; 2007 Oct; 246(4):624-8; discussion 628-31. PubMed ID: 17893499
[TBL] [Abstract][Full Text] [Related]
32. Adjuvant concurrent chemoradiotherapy with intensity-modulated pelvic radiotherapy after surgery for high-risk, early stage cervical cancer patients.
Chen MF; Tseng CJ; Tseng CC; Yu CY; Wu CT; Chen WC
Cancer J; 2008; 14(3):200-6. PubMed ID: 18536561
[TBL] [Abstract][Full Text] [Related]
33. Radiotherapy for early-stage Hodgkin's lymphoma: a 21st century perspective and review of multiple randomized clinical trials.
Bar Ad V; Paltiel O; Glatstein E
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1472-9. PubMed ID: 19028275
[TBL] [Abstract][Full Text] [Related]
34. The multidisciplinary management of rectal cancer.
Meredith KL; Hoffe SE; Shibata D
Surg Clin North Am; 2009 Feb; 89(1):177-215, ix-x. PubMed ID: 19186236
[TBL] [Abstract][Full Text] [Related]
35. Impact of intensity-modulated radiation therapy on local control in primary soft-tissue sarcoma of the extremity.
Alektiar KM; Brennan MF; Healey JH; Singer S
J Clin Oncol; 2008 Jul; 26(20):3440-4. PubMed ID: 18612160
[TBL] [Abstract][Full Text] [Related]
36. Increased risk of stroke and transient ischemic attack in 5-year survivors of Hodgkin lymphoma.
De Bruin ML; Dorresteijn LD; van't Veer MB; Krol AD; van der Pal HJ; Kappelle AC; Boogerd W; Aleman BM; van Leeuwen FE
J Natl Cancer Inst; 2009 Jul; 101(13):928-37. PubMed ID: 19535773
[TBL] [Abstract][Full Text] [Related]
37. Technical and dosimetric considerations in multi-isocenter intensity modulated radiotherapy for nasopharyngeal carcinoma with small multileaf collimator.
Xiance J; Shixiu W; Jianyi Y; Jinling Y
Med Dosim; 2009; 34(1):9-15. PubMed ID: 19181249
[TBL] [Abstract][Full Text] [Related]
38. Low-dose involved-field radiotherapy as alternative treatment of nodular lymphocyte predominance Hodgkin's lymphoma.
Haas RL; Girinsky T; Aleman BM; Henry-Amar M; de Boer JP; de Jong D
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1199-202. PubMed ID: 19131186
[TBL] [Abstract][Full Text] [Related]
39. Radiation therapy can still be used safely in combined modality approaches in patients with Hodgkin's lymphoma.
Dabaja B; Cox JD; Buchholz TA
J Clin Oncol; 2007 Jan; 25(1):3-5. PubMed ID: 17194900
[No Abstract] [Full Text] [Related]
40. Biological factors and therapeutic modulation in brain tumor radiotherapy.
De Santis M; Caiazza A; Simili A
Rays; 2002; 27(3):201-3. PubMed ID: 12696250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
